Avalun is the startup behind the LabPad® Evolution, a pocket-sized lab that can perform multiple biological analyses from just a finger prick of blood.
Avalun is the startup behind the LabPad® Evolution, a pocket-sized lab that can perform multiple biological analyses from just a finger prick of blood.
Avalun’s LabPad Evolution. © Avalun
A miniature, automated microscope built from two CMOS sensors is what allows the LabPad® to perform multiple lab-quality measurements. The reagents required for the tests take the form of consumable micro-cartridges. Blood tests can be done anywhere from a single finger prick, and the results are sent via Bluetooth to a smartphone or tablet.
Avalun’s device, widely distributed in France and other European countries, facilitates point-of-care testing in hospitals, and is also of interest to biology laboratories, general practitioners, nurses, nursing homes, and other healthcare stakeholders.
It can measure blood clotting time in patients on anticoagulants, C-reactive protein to detect viral or bacterial infections, and D-dimer if cardiac embolism is suspected.
Founded by two CEA engineers, Avalun’s IP portfolio includes nine CEA patents. In 2021, the startup was acquired by Biosynex.
Key figure: 300
Avalun offers the lightest biological analysis device on the market at only 300 grams, compared to 1.5 kilograms for its closest contender.
Key markets
- Hospitals
- Outpatient medicine
- Medical offices
- Home care
Technology used
- Lensless microscopy
- Microfluidics
- Rapid reading of fluorescent optical measurements
- Transmission of results via Bluetooth
Year founded: 2013
CEA institute: CEA-Leti